PY0101564A - Triazine containing anionic compounds useful as antiviral agents - Google Patents

Triazine containing anionic compounds useful as antiviral agents

Info

Publication number
PY0101564A
PY0101564A PY200100101564A PY0101564A PY0101564A PY 0101564 A PY0101564 A PY 0101564A PY 200100101564 A PY200100101564 A PY 200100101564A PY 0101564 A PY0101564 A PY 0101564A PY 0101564 A PY0101564 A PY 0101564A
Authority
PY
Paraguay
Prior art keywords
containing anionic
compounds useful
antiviral agents
anionic compounds
compounds
Prior art date
Application number
PY200100101564A
Other languages
English (en)
Inventor
A Nikitenko Antonina
Mitsner Boris
M O O´Hara Bryan
A Ellestad George
P Larocque James
E Morin John
Ding Wei-Dong
Gluzman Yakov
E Raifeld Yuri
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of PY0101564A publication Critical patent/PY0101564A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/42—One nitrogen atom
    • C07D251/44—One nitrogen atom with halogen atoms attached to the two other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms
    • C07D251/50—Two nitrogen atoms with a halogen atom attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms
    • C07D251/52—Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/70—Other substituted melamines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

This invention provides triazine ring containing anionic compounds, pharmaceutical compositions containing these compounds and methods utilizing these compounds for treating viral infections, particularly infections by respiratory syncitial virus, the,compounds having the general structure
PY200100101564A 1997-01-27 2001-01-26 Triazine containing anionic compounds useful as antiviral agents PY0101564A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/789,038 US5852015A (en) 1997-01-27 1997-01-27 Triazine containing anionic compounds useful as antiviral agents

Publications (1)

Publication Number Publication Date
PY0101564A true PY0101564A (es) 2001-12-03

Family

ID=25146386

Family Applications (1)

Application Number Title Priority Date Filing Date
PY200100101564A PY0101564A (es) 1997-01-27 2001-01-26 Triazine containing anionic compounds useful as antiviral agents

Country Status (4)

Country Link
US (1) US5852015A (es)
CA (1) CA2197394A1 (es)
NZ (1) NZ328399A (es)
PY (1) PY0101564A (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002062769A2 (en) 2001-02-02 2002-08-15 Wyeth Preparation and purification of antiviral disulfonic acid disodium salt
US20070098676A1 (en) * 2005-08-10 2007-05-03 Simanek Eric E Functionally diverse macromolecules and their synthesis
WO2008001368A2 (en) * 2006-06-27 2008-01-03 Hadasit Medical Research Services And Development Ltd. Use of stilbene derivatives for treatment and prevention of aquatic mold infections
US8815295B1 (en) 2011-12-22 2014-08-26 Alabama State University Anti respiratory syncytial virus peptide functionalized gold nanoparticles
US10736821B2 (en) * 2015-05-15 2020-08-11 University Of Massachusetts Preparation and use of silver sulfadiazine-immobilized fillers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0626945B1 (en) * 1992-02-20 1998-04-22 Merrell Pharmaceuticals Inc. Sulfonic acid derivatives in the treatment of viral diseases
CH686959A5 (de) * 1992-12-22 1996-08-15 Ciba Geigy Ag Lagerstabile Formulierung von optischen Aufhellern.

Also Published As

Publication number Publication date
CA2197394A1 (en) 1998-07-27
US5852015A (en) 1998-12-22
NZ328399A (en) 2001-04-27

Similar Documents

Publication Publication Date Title
DE69811062D1 (de) Polyaromatische antivirale zusammensetzungen
ATE295355T1 (de) Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
EA199901031A1 (ru) Производные бензимидазола
BR0309581A (pt) Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
ATE245641T1 (de) Antivirale pyrimidinderivate
BR0305259A (pt) Inibidores de hcv ns5b polimerase
DK1200418T3 (da) Nematodicide trifluorbutener
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
GB0011203D0 (en) Chemical compounds
BR9815166A (pt) "método de inibição da replicação de vìrus, composto, método de inibição da replicação de citomegalovìrus, composto antiviral, utilização de um composto, composição farmacêutica, composição farmacêutica inibidora da replicação de vìrus e de citomegalovìrus e composição farmacêutica antiviral"
PT1200412E (pt) Agentes anti-proliferativos de imidazole
DE69430611D1 (de) Phosphonooxymethyl oder Methylthiomethylether von Taxanderivaten als Antitumormittel
DK0821690T3 (da) Nukleotidanaloger til behandling af virusinfektioner
ES2189404T3 (es) 1,3,4-tiadiazoles utiles para el tratamiento de infecciones por cmv.
DE60212949D1 (de) Antivirale pyrazolopyridin verbindungen
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
ES2243579T3 (es) Derivados de pirazolopirideno.
DK1037650T3 (da) Præparater til behandling af Staphylococcus aureus-infektioner
TR200402534T4 (tr) Viral enfeksiyonların tedavisinde yararlı oksazinokuinolonlar.
MXPA04006041A (es) Antivirales de piridoquinoxalina.
BR0111729A (pt) 1-aril-4-oxo-1,4-dihidro-3-quinolinacarboxamidas como agentes antivirais
ATE266400T1 (de) Heterocyclyl sulphonamid derivate
EA200100711A1 (ru) Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция
WO2002072581A3 (en) Pyrazolopyriadine derivatives
SE9904128D0 (sv) Novel compounds